Teva Canadal launches bioequivalent generic version of [Pr]Gilenya, [Pr]Teva-Fingolimod capsules
Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of PrTeva-Fingolimod 0.5 mg capsules, a Health Canada approved, bioequivalent generic version of PrGilenya (fingolimod hydrochloride) in Canada.